Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Revised Definition of Extensively Drug-Resistant Tuberculosis. Morbidity and Mortality Weekly Report, 55(43): 1176, November 3, 2006.

Report
Revised Definition of Extensively Drug-Resistant Tuberculosis. Morbidity and Mortality Weekly Report, 55(43): 1176, November 3, 2006.

As a result of the first meeting of the Global XDR TB Task Force (October 6-7, 2006), the case definition of extensively drug-resistant tuberculisis (XDR TB) was revised. This Notice to Readers details the events leading up to this revision and the new case definition.

Author:

Centers for Disease Control and Prevention (CDC), US Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention (CDC), National Center for Health Statistics, Office of the Morbidity and Mortality Weekly Report Series, CDC MMWR

Audiences:

Policy Makers

Topic:

MDR TB

Country of Origin:

United States

View Webpage

Related Materials

Emergence of Mycobacterium tuberculosis with Extensive Resistance to Second-Line Drugs — Worldwide, 2000–2004. Morbidity and Mortality Weekly Report, 55(11): 301-305, March 24, 2006.

During November 2004 - November 2005, CDC and WHO surveyed an international network of TB laboratories to assess the frequency and distribution of extensively drug-resistant (XDR) TB cases. This report summarizes the results of that survey.

Report

Definitions and Reporting Framework for Tuberculosis – 2013 Revision

This document revises previous WHO standard case definitions for TB and drug-resistant TB, the categories used to assign outcomes, and the standard reporting framework for TB.

Book

Emergence of Extensively Drug Resistant Tuberculosis

Extensively drug-resistant tuberculosis (XDR TB) outbreaks have been reported in South Africa, and strains have been identified on 6 continents. Dr. Peter Cegielski, team leader for drug-resistant TB with the Division of Tuberculosis Elimination at CDC, comments on a multinational team's report on this emerging global public health threat.

Webpage

Global resources for the prevention,
management, and elimination of TB.